Literature DB >> 22644156

Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation.

Catia Contado1, Eleonora Vighi, Alessandro Dalpiaz, Eliana Leo.   

Abstract

Poly(lactic-co-glycolic acid) particles in the 200-400-nm size range were formulated through nanoprecipitation and solvent evaporation methods. Different concentrations of the polymer and stabilizer (Pluronic® F 68) were tested in order to identify the best conditions for making poly(lactic-co-glycolic acid) particles of suitable size, stable in time, and to be used as carriers for brain-targeting drugs. The particles with the best characteristics for delivery system design were those formulated by nanoprecipitation with an organic/water phase ratio of 2:30, a polymer concentration of 25 mg/mL, and a surfactant concentration of 0.83 mg/mL; their surface charge was reasonably negative (approximately -27 mV) and the average size of the almost monodisperse population was roughly 250 nm. Particle characterization was obtained through ζ-potential measurements, scanning electron microscope observations, and particle size distribution determinations; the latter achieved by both photon-correlation spectroscopy and sedimentation field flow fractionation. Sedimentation field flow fractionation, which is considered more reliable than photon-correlation spectroscopy in describing the possible particle size distribution modifications, was used to investigate the effects of 3 months of storage at 4 °C had on the lyophilized particles. Figure Particle size ditribution from the SdFFF and the PCS techniques.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22644156     DOI: 10.1007/s00216-012-6113-5

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  9 in total

1.  Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival.

Authors:  Baharak Bahmani; Mayuko Uehara; Liwei Jiang; Farideh Ordikhani; Naima Banouni; Takaharu Ichimura; Zhabiz Solhjou; Georg J Furtmüller; Gerald Brandacher; David Alvarez; Ulrich H von Andrian; Kenji Uchimura; Qiaobing Xu; Ishaan Vohra; Osman A Yilmam; Yousef Haik; Jamil Azzi; Vivek Kasinath; Jonathan S Bromberg; Martina M McGrath; Reza Abdi
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

2.  Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.

Authors:  Yichao Wang; Puwang Li; Lingxue Kong
Journal:  AAPS PharmSciTech       Date:  2013-03-06       Impact factor: 3.246

3.  Tuning the Size of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation.

Authors:  Wei Huang; Chenming Zhang
Journal:  Biotechnol J       Date:  2017-10-13       Impact factor: 4.677

4.  Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation.

Authors:  Ying Cheng; Miao Liu; Huijing Hu; Daozhou Liu; Siyuan Zhou
Journal:  AAPS PharmSciTech       Date:  2015-07-21       Impact factor: 3.246

5.  Development of PLGA-based itraconazole injectable nanospheres for sustained release.

Authors:  Xiaomei Bian; Su Liang; Jyothy John; Cheng-Hui Hsiao; Xin Wei; Dong Liang; Huan Xie
Journal:  Int J Nanomedicine       Date:  2013-11-21

Review 6.  Manufacturing Techniques and Surface Engineering of Polymer Based Nanoparticles for Targeted Drug Delivery to Cancer.

Authors:  Yichao Wang; Puwang Li; Thao Truong-Dinh Tran; Juan Zhang; Lingxue Kong
Journal:  Nanomaterials (Basel)       Date:  2016-02-01       Impact factor: 5.076

7.  Design of Non-Haemolytic Nanoemulsions for Intravenous Administration of Hydrophobic APIs.

Authors:  Line Séguy; Anne-Claire Groo; Didier Goux; Didier Hennequin; Aurélie Malzert-Fréon
Journal:  Pharmaceutics       Date:  2020-11-25       Impact factor: 6.321

Review 8.  Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines.

Authors:  Mazen M El-Hammadi; José L Arias
Journal:  Nanomaterials (Basel)       Date:  2022-01-22       Impact factor: 5.076

Review 9.  Particles from preformed polymers as carriers for drug delivery.

Authors:  K Miladi; D Ibraheem; M Iqbal; S Sfar; H Fessi; A Elaissari
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.